Press Releases

Below you will find the latest press releases from Evolva. You are also welcome to dive into the archive and browse our press releases from there as well:

Latest Press Releases

Reinach, Switzerland, 7 May 2013 – The Annual General Meeting of Evolva Holding SA (SIX: EVE) has approved all proposals put forward by the Board of Directors.

Reinach, Switzerland, 9 April 2013 – Evolva Holding SA (SIX: EVE) today announced its financial results for the period 1 January to 31 December 2012.

Reinach, Switzerland, 27 March 2013 — Evolva Holding SA (SIX: EVE, “Evolva”) today reports the completion of the capital increase that was announced on 6 March 2013. The offering provides Evolva with gross proceeds of CHF 31.3 million before transaction costs.

Preliminary 2012 loss lower than expected

Reinach, Switzerland, 20 March 2013 — Evolva Holding SA (SIX: EVE, “Evolva”) today announced that its offering (announced on 6 March 2013) was fully subscribed by existing and new shareholders. The offering provides Evolva with gross proceeds of CHF 31.3 million before transaction costs.

Collaboration lays foundation for next evolution in stevia industry

Reinach, Switzerland 6 March 2013 —Evolva Holding SA (SIX: EVE) today announced that it has entered into an agreement with Cargill to jointly develop and commercialize fermentation-derived steviol glycosides. Cargill will be responsible for commercialization and has agreed to make a CHF 5 million (approximately USD 5.3 million) equity investment in Evolva.

CHF 28.5 million committed by Cargill, investors, Evolva’s board and management

Reinach, Switzerland, 6 March 2013 — Evolva Holding SA (SIX: EVE, “Evolva” or the “Company”) today announces the start of its capital increase. Evolva will raise up to CHF 31.3 million by means of a rights issue to existing shareholders.

Reinach, Switzerland, 18 February 2013 - Evolva Holding SA (SIX: EVE) today updated its financial guidance of November 2012.

New York, 5 February 2013 – International Flavors & Fragrances Inc. (NYSE: IFF) and Evolva Holding SA (SIX: EVE), today announced that they have entered into pre-production phase to develop and scale-up, via a third party, natural vanillin for commercial application through a cost-effective, natural and sustainable route.

Reinach, Switzerland, 29 January 2013 – Evolva Holding SA (SIX: EVE) today announced that it has achieved a key milestone in its collaboration with BASF (announced in March 2011). The collaboration involves joint research on the design of novel and optimised biosynthetic routes for a natural product with crop protection potential.

Reinach, Switzerland, 17 January 2013 - Evolva Holding SA (SIX: EVE) today announced that it has entered into a collaboration agreement with Ajinomoto Co. Inc., Japan, for the joint development of novel fermentation production routes for a natural functional ingredient for application in Personal Care.

Contact Information

Evolva SA
Duggingerstrasse 23
CH-4153 Reinach
Switzerland
Tel: +41 61 485 2000
Fax: +41 61 485 2001
Evolva A/S
Lersoe Parkallé 42-44
DK-2100 Copenhagen OE
Denmark
Tel: +45 35 200 230
Fax: +45 35 200 231
Evolva Biotech Private Limited
401 - 405, 4th Floor
Ticel Bio Park Ltd
Taramani Road, Taramani
Chennai 600 113
Tamil Nadu, India
Tel: +91 44 4297 1050
Fax: +91 44 4297 1060
Evolva, Inc. (Evolva USA)
2440 Embarcadero Way
Palo Alto
CA 94303
USA
Tel: +1 650 856 2436
Fax: +1 650 856 7950

General Enquiries: info@evolva.com • Business Enquiries: busdev@evolva.com • India Enquiries: info_india@evolva.com